Regeneron Pharmaceuticals, Inc.
Profit History
| Fiscal Year | Revenue | Operating Income | Net Income |
|---|---|---|---|
| FY2021 | $16.07B | $8.95B | $8.08B |
| FY2022 | $12.17B | $4.74B | $4.34B |
| FY2023 | $13.12B | $4.05B | $3.95B |
| FY2024 | $14.20B | $3.99B | $4.41B |
| FY2025 | $14.34B | $3.58B | $4.50B |
Profit History
| Fiscal Year | Revenue | Operating Income | Net Income |
|---|---|---|---|
| FY2021 | $16.07B | $8.95B | $8.08B |
| FY2022 | $12.17B | $4.74B | $4.34B |
| FY2023 | $13.12B | $4.05B | $3.95B |
| FY2024 | $14.20B | $3.99B | $4.41B |
| FY2025 | $14.34B | $3.58B | $4.50B |